Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.

M.H.G. Langenberg; C.M. van Herpen; J. de Bono; J.H.M. Schellens; C Unger; K. Hoekman; H.E. Blum; W. Fiedler; J. Drevs; F. le Maulf; A. Fielding; J. Robertson; E.E. Voest

Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.

M.H.G. Langenberg
, C.M. van Herpen
, J. de Bono
, J.H.M. Schellens
, C Unger
, K. Hoekman
, H.E. Blum
, W. Fiedler
, J. Drevs
, F. le Maulf
, A. Fielding
, J. Robertson
, E.E. Voest

Dept of Pharmaceutical Sciences

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	6152-6159
Number of pages	8
Journal	Journal of Clinical Oncology
Volume	27
Issue number	36
Publication status	Published - 2009

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/19901116

Cite this

Langenberg, M. H. G., van Herpen, C. M., de Bono, J., Schellens, J. H. M., Unger, C., Hoekman, K., Blum, H. E., Fiedler, W., Drevs, J., le Maulf, F., Fielding, A., Robertson, J., & Voest, E. E. (2009). Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors. Journal of Clinical Oncology, 27(36), 6152-6159. http://www.ncbi.nlm.nih.gov/pubmed/19901116

Langenberg, M.H.G. ; van Herpen, C.M. ; de Bono, J. et al. / Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors. In: Journal of Clinical Oncology. 2009 ; Vol. 27, No. 36. pp. 6152-6159.

@article{35dbf84b78174362b96cb26221930b63,

title = "Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.",

author = "M.H.G. Langenberg and \{van Herpen\}, C.M. and \{de Bono\}, J. and J.H.M. Schellens and C Unger and K. Hoekman and H.E. Blum and W. Fiedler and J. Drevs and \{le Maulf\}, F. and A. Fielding and J. Robertson and E.E. Voest",

year = "2009",

language = "Undefined/Unknown",

volume = "27",

pages = "6152--6159",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "36",

}

Langenberg, MHG, van Herpen, CM, de Bono, J, Schellens, JHM, Unger, C, Hoekman, K, Blum, HE, Fiedler, W, Drevs, J, le Maulf, F, Fielding, A, Robertson, J & Voest, EE 2009, 'Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.', Journal of Clinical Oncology, vol. 27, no. 36, pp. 6152-6159. <http://www.ncbi.nlm.nih.gov/pubmed/19901116>

Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors. / Langenberg, M.H.G.; van Herpen, C.M.; de Bono, J. et al.
In: Journal of Clinical Oncology, Vol. 27, No. 36, 2009, p. 6152-6159.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.

AU - Langenberg, M.H.G.

AU - van Herpen, C.M.

AU - de Bono, J.

AU - Schellens, J.H.M.

AU - Unger, C

AU - Hoekman, K.

AU - Blum, H.E.

AU - Fiedler, W.

AU - Drevs, J.

AU - le Maulf, F.

AU - Fielding, A.

AU - Robertson, J.

AU - Voest, E.E.

PY - 2009

Y1 - 2009

M3 - Article

SN - 0732-183X

VL - 27

SP - 6152

EP - 6159

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 36

ER -

Langenberg MHG, van Herpen CM, de Bono J, Schellens JHM, Unger C, Hoekman K et al. Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors. Journal of Clinical Oncology. 2009;27(36):6152-6159.